Welcome to our dedicated page for USBC SEC filings (Ticker: USBC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The USBC, Inc. (NYSE American: USBC) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, along with AI-powered summaries that help explain complex documents in plain language. USBC is a Nevada-incorporated, publicly traded, multi-disciplinary technology company that focuses on digital financial technologies, including tokenized U.S. dollar deposits and a Bitcoin treasury strategy, as well as non-invasive health monitoring research.
Through its registration statements on Form S-1 and S-1/A, USBC outlines its business overview, corporate history, and strategic transition from its legacy non-invasive sensor technology operations as Know Labs, Inc. to a broader financial technology platform. These filings describe the USBC tokenized deposit offering, a U.S.-dollar denominated tokenized representation of a bank deposit account that operates on blockchain technology and is embedded with digital identity, and detail the establishment of a Bitcoin treasury as a primary reserve asset.
Current and prospective investors can review USBC’s Forms 8-K for information on material events, including the strategic investment by Goldeneye 1995 LLC, changes to its equity incentive plans, executive departures and related separation agreements, option repricing and new equity grants, and amendments to digital asset management agreements for its Bitcoin treasury strategy. These filings also document the company’s name and ticker change to USBC, Inc. and “USBC” on the NYSE American.
On Stock Titan, AI-generated insights highlight key sections of USBC’s filings, such as risk factor discussions, descriptions of the tokenized deposit model and Bitcoin treasury program, and details of significant capital transactions. Users can also track updates related to equity compensation plans and governance decisions reported under Item 5.02 of Form 8-K. Real-time integration with EDGAR helps ensure that new USBC filings, including future annual reports on Form 10-K, quarterly reports on Form 10-Q, and additional 8-Ks, are quickly available with concise explanations of their main points.
USBC, Inc. entered into a Capital on Demand at-the-market equity program with JonesTrading that originally allowed sales of up to $5,000,000 of common stock. The company has now increased the amount available for sale under this Sales Agreement to an aggregate offering price of up to $14,500,000, using its already effective $18,000,000 shelf registration on Form S-3.
There is no minimum sale requirement, so the actual number of shares sold and total proceeds will depend on future market transactions. USBC plans to use any net proceeds primarily for general corporate purposes, including working capital and capital expenditures. Since December 31, 2024, the company has sold 1,708,124 shares under the program for gross proceeds of approximately $1,269,236, and common shares outstanding were 384,234,130 as of September 4, 2025.
USBC, Inc. discloses portions of its definitive proxy statement including director background, related-party professional fees and governance procedures. The filing states that Mr. Cronin holds multiple engineering degrees and a B.A. in Psychology from the University of Vermont. The company reports it paid ipCG approximately $390,000 for the year ended September 30, 2024 and $713,000 for the year ended September 30, 2023 in professional fees. It also states Mr. Cronin is not considered an independent director because of prior service as Interim Chief Technology Officer from September 2024 to August 2025. The document includes placeholders for compensation components such as base salary, stock options, benefits and accrued vacation pay and restates proxy submission requirements for shareholder proposals.